check_circleStudy Completed

Endometriosis

Bayer Identifier:

15687

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

EudraCT Number 2011-001503-12

EU CT Number:

Not Available
AI plus P IVR: LNG Tabl PK, MD

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years
  • -

  • -

Trial summary

Enrollment Goal
21
Trial Dates
September 2011 - December 2011
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Levonorgestrel (Microlut, BAY86-5028)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer Pharma AGBerlin, 13353, Germany

Trial design

Single-center, open-label, single treatment study to determine the pharmacokinetics of levonorgestrel (LNG) after repeated oral administration of 0.03 mg per day for at least 28 days in 20 healthy female subjects of reproductive age
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.